arBtrage CAPITALIZING MARKETS checking… Sign in

Inhibrx Biosciences, Inc.

INBX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$87.01
▼ -4.7% Today
as of Jun 7, 07:18 ET
Last 30 days -33.41% Apr 28 → Jun 05
$82.62 $98.52 $114.42 $130.33 $146.23 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$90.08
High
$92.73
Low
$85.48
Volume
$299,801
Avg Vol
$277,194
Mkt Cap
$1.5B
P/E (TTM)
Beta
52w High
$155.29
52w Low
$12.80
Div Yield
Shares Out
$15M

Overview

52-week range
$13
$155
52% of range
Avg surprise (last 2)
-0.3%
Avg reaction (last 2)
-2.7%
0% positive
Latest IV / EM
118%
EM ±16.3% · $85 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-5.77$27.04$59.86$92.67$125.48 Actual $-4.31Actual $-4.39Actual $-5.77Actual $125.48Actual $-2.84Actual $-2.80Est $-2.55Actual $-1.85Actual $-2.28Actual $-2.15Est $-2.37 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-44M$455M$954M$1.5B$2.0B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-2.15 $-2.37 +9.3% +23.2% -1.5% earnings
Tue Sep 30, 2025Sep 2025 $-2.28 financials
Mon Jun 30, 2025Jun 2025 $-1.85 financials
Wed May 14, 2025Mar/2025 $-2.80 $-2.55 -9.8% -3.9% earnings
Mon Sep 30, 2024Sep 2024 $-2.84 financials
Sun Jun 30, 2024Jun 2024 $125.48 financials
Sun Mar 31, 2024Mar 2024 $-5.77 financials
Sat Sep 30, 2023Sep 2023 $-4.39 financials
Fri Jun 30, 2023Jun 2023 $-4.31 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$1M$0$0$100,000
Cost of revenue
Gross profit
Operating income$-31M$-34M$-27M$-43M$-47M$-161M
Net income$-33M$-35M$-29M$-43M$-44M$1.86B
EPS (diluted)$-2.15$-2.28$-1.85$-2.80$-2.84$125.48

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$162M$124M$153M$187M$217M$153M$196M$227M
Inventory
Total current assets$171M$133M$161M$194M$223M$160M$207M$242M
Total assets$184M$146M$177M$212M$243M$181M$223M$258M
Long-term debt$175M$101M$100M$99M$99M$0$0$0
Total liabilities$205M$138M$141M$144M$148M$47M$44M$39M
Total equity$-21M$8M$37M$69M$94M$134M$178M$219M

Implied volatility — last 90 days

112%115%117%120%122% Jun 07 — IV 118% · EM ±16.3%

Sector peers